
Bruck Kifle
Examiner (ID: 2332)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1202, 1624, 1611, 1622 |
| Total Applications | 3434 |
| Issued Applications | 2601 |
| Pending Applications | 222 |
| Abandoned Applications | 651 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 8990395
[patent_doc_number] => 20130217676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-08-22
[patent_title] => '5HT2C RECEPTOR MODULATORS'
[patent_app_type] => utility
[patent_app_number] => 13/616981
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 27276
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13616981
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/616981 | 5HT2C receptor modulators | Sep 13, 2012 | Issued |
Array
(
[id] => 10627564
[patent_doc_number] => 09345703
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-05-24
[patent_title] => 'Kappa opioid receptor effectors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/345273
[patent_app_country] => US
[patent_app_date] => 2012-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 12158
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345273
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/345273 | Kappa opioid receptor effectors and uses thereof | Sep 13, 2012 | Issued |
Array
(
[id] => 8607218
[patent_doc_number] => 20130012529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-10
[patent_title] => 'HETEROBICYCLIC CARBOXAMIDES AS INHIBITORS FOR KINASES'
[patent_app_type] => utility
[patent_app_number] => 13/613062
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 136300
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613062
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/613062 | Heterobicyclic carboxamides as inhibitors for kinases | Sep 12, 2012 | Issued |
Array
(
[id] => 9046879
[patent_doc_number] => 08541432
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-09-24
[patent_title] => 'Heterobicyclic carboxamides as inhibitors for kinases'
[patent_app_type] => utility
[patent_app_number] => 13/613053
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 130344
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613053
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/613053 | Heterobicyclic carboxamides as inhibitors for kinases | Sep 12, 2012 | Issued |
Array
(
[id] => 8586929
[patent_doc_number] => 20130005750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-03
[patent_title] => 'HETEROBICYCLIC CARBOXAMIDES AS INHIBITORS FOR KINASES'
[patent_app_type] => utility
[patent_app_number] => 13/613019
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 126408
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613019
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/613019 | Heterobicyclic carboxamides as inhibitors for kinases | Sep 12, 2012 | Issued |
Array
(
[id] => 8921020
[patent_doc_number] => 08486954
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-07-16
[patent_title] => 'Heterobicyclic carboxamides as inhibitors for kinases'
[patent_app_type] => utility
[patent_app_number] => 13/613034
[patent_app_country] => US
[patent_app_date] => 2012-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 134991
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613034
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/613034 | Heterobicyclic carboxamides as inhibitors for kinases | Sep 12, 2012 | Issued |
Array
(
[id] => 10096873
[patent_doc_number] => 09133174
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-09-15
[patent_title] => 'Method for producing coumarin derivative'
[patent_app_type] => utility
[patent_app_number] => 14/342629
[patent_app_country] => US
[patent_app_date] => 2012-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15247
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342629
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342629 | Method for producing coumarin derivative | Sep 4, 2012 | Issued |
Array
(
[id] => 9813119
[patent_doc_number] => 20150025064
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-22
[patent_title] => 'NOVEL BENZODIAZEPINONES AS MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR FUNCTIONS AND NEUROLOGICAL USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/342339
[patent_app_country] => US
[patent_app_date] => 2012-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 35575
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14342339
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/342339 | Benzodiazepinones as modulators of metabotropic glutamate receptor functions and neurological uses thereof | Aug 28, 2012 | Issued |
Array
(
[id] => 8523384
[patent_doc_number] => 20120322793
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-20
[patent_title] => 'PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/593674
[patent_app_country] => US
[patent_app_date] => 2012-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20059
[patent_no_of_claims] => 68
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13593674
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/593674 | Protein kinase inhibitors | Aug 23, 2012 | Issued |
Array
(
[id] => 9530226
[patent_doc_number] => 08754098
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-17
[patent_title] => 'Forms of rifaximin and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 13/593453
[patent_app_country] => US
[patent_app_date] => 2012-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 48
[patent_figures_cnt] => 48
[patent_no_of_words] => 21961
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13593453
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/593453 | Forms of rifaximin and uses thereof | Aug 22, 2012 | Issued |
Array
(
[id] => 8660112
[patent_doc_number] => 20130040941
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'BENZODIAZEPINE COMPOUND AND PHARMACEUTICAL COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 13/591361
[patent_app_country] => US
[patent_app_date] => 2012-08-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 80022
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13591361
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/591361 | Benzodiazepine compound and pharmaceutical composition | Aug 21, 2012 | Issued |
Array
(
[id] => 9427680
[patent_doc_number] => 08703755
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-04-22
[patent_title] => 'Analogs of benzoquinone-containing ansamycins and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 13/589581
[patent_app_country] => US
[patent_app_date] => 2012-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 88
[patent_figures_cnt] => 90
[patent_no_of_words] => 38820
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13589581
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/589581 | Analogs of benzoquinone-containing ansamycins and methods of use thereof | Aug 19, 2012 | Issued |
Array
(
[id] => 10940026
[patent_doc_number] => 20140343047
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'TETRANDRINE DERIVATIVES WITH SUBSTITUTED 5-CARBON, PREPARATION METHOD AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/239759
[patent_app_country] => US
[patent_app_date] => 2012-08-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 24757
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239759
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/239759 | Tetrandrine derivatives with substituted 5-carbon, preparation method and use thereof | Aug 19, 2012 | Issued |
Array
(
[id] => 9603661
[patent_doc_number] => 20140200343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-07-17
[patent_title] => 'PROCESS AND INTERMEDIATES FOR PREPARING MACROLACTAMS'
[patent_app_type] => utility
[patent_app_number] => 14/239393
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 12948
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239393
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/239393 | Process and intermediates for preparing macrolactams | Aug 15, 2012 | Issued |
Array
(
[id] => 8516926
[patent_doc_number] => 20120316334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-13
[patent_title] => 'FORMS OF RIFAXIMIN AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/587537
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 18230
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587537
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/587537 | Forms of rifaximin and uses thereof | Aug 15, 2012 | Issued |
Array
(
[id] => 9686754
[patent_doc_number] => 20140243519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'METHODS AND INTERMEDIATES FOR PREPARING MACROLACTAMS'
[patent_app_type] => utility
[patent_app_number] => 14/239391
[patent_app_country] => US
[patent_app_date] => 2012-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 12573
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14239391
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/239391 | Methods and intermediates for preparing macrolactams | Aug 15, 2012 | Issued |
Array
(
[id] => 8660146
[patent_doc_number] => 20130040975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-02-14
[patent_title] => 'GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS RELATING THERETO'
[patent_app_type] => utility
[patent_app_number] => 13/572510
[patent_app_country] => US
[patent_app_date] => 2012-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27702
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13572510
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/572510 | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto | Aug 9, 2012 | Issued |
Array
(
[id] => 8510335
[patent_doc_number] => 20120309743
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-12-06
[patent_title] => 'THIOLACTAMS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/570486
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38904
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13570486
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/570486 | Thiolactams and uses thereof | Aug 8, 2012 | Issued |
Array
(
[id] => 8503144
[patent_doc_number] => 20120302551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-29
[patent_title] => 'THIOLACTAMS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 13/570518
[patent_app_country] => US
[patent_app_date] => 2012-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39149
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13570518
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/570518 | THIOLACTAMS AND USES THEREOF | Aug 8, 2012 | Abandoned |
Array
(
[id] => 10192923
[patent_doc_number] => 09221818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-12-29
[patent_title] => 'Macrocycles as factor XIa inhibitors'
[patent_app_type] => utility
[patent_app_number] => 14/236973
[patent_app_country] => US
[patent_app_date] => 2012-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 113805
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236973
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/236973 | Macrocycles as factor XIa inhibitors | Aug 5, 2012 | Issued |